Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine

Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine

Antiretroviral therapy has dramatically reduced mother-to-child transmission of HIV. In this report, the comparative safety of different treatment regimens was assessed.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2018-04, Vol.378 (17), p.1593-1603
Hauptverfasser: Rough, Kathryn, Seage, George R, Williams, Paige L, Hernandez-Diaz, Sonia, Huo, Yanling, Chadwick, Ellen G, Currier, Judith S, Hoffman, Risa M, Barr, Emily, Shapiro, David E, Patel, Kunjal
Format: Artikel
Sprache:eng
Schlagworte:
Acquired immune deficiency syndrome
AIDS
Antiretroviral drugs
Antiretroviral therapy
Antiviral drugs
Clinical outcomes
Emtricitabine
Fetuses
Gestation
HIV
Human immunodeficiency virus
Infants
Intrauterine exposure
Lamivudine
Lopinavir
Low birth weight
Maternal & child health
Pregnancy
Premature birth
Ritonavir
Tenofovir
Womens health
Zidovudine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Antiretroviral therapy has dramatically reduced mother-to-child transmission of HIV. In this report, the comparative safety of different treatment regimens was assessed.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1701666